Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dissertation for student changed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study determines whether different forms of ketones supplemented prior to a meal lower the triglyceride (fat) content in the blood of overweight and obese individuals. Through a randomized crossover design, participants (n=15) will participate in each of the following three experimental groups (no treatment control, ketone ester, ketone salt), with a 5-14 day washout period between each experimental visit.
Previous studies conducted by the investigative team in rodents show that male mice fed a diet containing 30% ketone ester (by kcals) results in greater fecal content and energy loss. While the investigators are unsure of the exact macronutrient content of the energy loss, the hypothesis is that the energy excretion is attributed to lower fat absorption. In the context of this study, it's hypothesized that ketone salts and ketone esters (both available commercially and used for a variety of health-related claims) will reduce the absorption of dietary fats leading to lower circulating triglyceride concentrations if consumed prior to a high-fat mixed meal. If the hypothesis is correct, ketones supplementation could become a valuable strategy to reduce the rise in circulating triglycerides often present in obesity. Triglyceride concentrations in the blood following a meal have been linked to development of cardiovascular disease.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | This arm receives no treatment control. | |
| Ketone Ester | Experimental | This arm receives 25 g ketone ester. |
|
| Ketone Salt | Experimental | This arm receives 25 g ketone salt. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ketone Ester | Dietary Supplement | This arm receives 25 g ketone ester. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline plasma glucagon-like peptide 1 at 240 minutes | Plasma levels of glucagon-like peptide 1 in pg/L | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
| Change from baseline serum triglycerides at 240 minutes | Serum levels of triglycerides in mg/DL | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
| Change from baseline serum glucose at 240 minutes | Serum levels of glucose in mg/dL | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
| Change from baseline serum Insulin at 240 minutes | Serum levels of insulin in pmol/L | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
| Change from baseline serum B-hydroxybutyrate at 240 minutes | Serum levels of B-hydroxybutyrate in mmol/L | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
| Change from baseline plasma ghrelin at 240 minutes | Plasma levels of ghrelin in pg/mL | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
| Change from baseline plasma leptin at 240 minutes | Plasma levels of leptin in ng/mL | 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D015228 | Hypertriglyceridemia |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
| ID | Term |
|---|---|
| C524675 | formic acid 4-(3-oxobutyl)phenyl ester |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ketone Salt |
| Dietary Supplement |
This arm receives 25 g ketone salt. |
|
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006949 | Hyperlipidemias |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |